Download the Case Study
The Medpace CPU’s Role in Guiding Biotech through a Complex Trial
The Medpace CPU’s Role in Guiding Biotech through a Complex Trial
Empowering Emerging Biotech in Phase I Trial
An emerging biotech with no prior Phase I experience partnered with the Medpace Clinical Pharmacology Unit (MCPU) to execute a Single Ascending Dose/Multiple Ascending Dose (SAD/MAD) clinical trial. With limited resources and expertise, the biotech relied on the MCPU’s comprehensive support to navigate the complexities of early-phase clinical development.
Download the newly released article to explore how the MCPU empowered an emerging biotech through a complex SAD/MAD trial.
Bridging Early-Phase Insight to Late Phase Development
The Medpace Phase I Unit
Discover the Medpace Phase I Unit’s state of the art facilities and comprehensive support services for accelerating early phase clinical development. Partner with us to bridge early phase insight to late phase successes. When partnering with the Phase I Unit, Sponsors benefit from:
- Early Phase Services & Study Designs
- State-of-the-Art Facilities & Equipment
- A Dedicated Pharmacy for Early-Phase Studies
- Effective Recruitment and Retention of Normal, Healthy, and Specialty Patient Populations
- Study Management Technology
Accelerate your early phase clinical development by contacting our experts today.
